Is Kodiak Sciences Inc (KOD) overvalued? · $1.94B cap
Kodiak Sciences Inc (KOD) is a biotechnology company listed on US.
This page asks whether Kodiak Sciences Inc (KOD) looks expensive on cached numbers — not a short thesis.
No cached income statement for KOD, so there is no earnings base to call rich or cheap.
KOD currently screens at market cap $1.94B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next KOD 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the KOD stock page for the full model, not this heading.
Not investment advice.